Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial

FIN-RACo Trial Group

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Pages (from-to)786-788
JournalANNALS OF THE RHEUMATIC DISEASES
Volume72
Issue number5
DOIs
Publication statusPublished - 2013
Externally publishedYes
Publication typeA1 Journal article-refereed

Publication forum classification

  • No publication forum level

Cite this